Works by Bergemalm, Daniel

Results: 29
    1

    Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 765, doi. 10.1111/apt.18154
    By:
    • Ling Lundström, Maria;
    • Peterson, Christer;
    • Hedin, Charlotte R. H.;
    • Bergemalm, Daniel;
    • Lampinen, Maria;
    • Magnusson, Maria K.;
    • Keita, Åsa V.;
    • Kruse, Robert;
    • Lindqvist, Carl Mårten;
    • Repsilber, Dirk;
    • D'Amato, Mauro;
    • Hjortswang, Henrik;
    • Strid, Hans;
    • Söderholm, Johan D.;
    • Öhman, Lena;
    • Venge, Per;
    • Halfvarson, Jonas;
    • Carlson, Marie
    Publication type:
    Article
    2

    Microbial Patterns in Newly Diagnosed Inflammatory Bowel Disease Revealed by Presence and Transcriptional Activity - Relationship to Diagnosis and Outcome.

    Published in:
    Clinical & Experimental Gastroenterology, 2025, v. 17, p. 103, doi. 10.2147/CEG.S504459
    By:
    • Vatn, Simen Svendsen;
    • Hansen, Simen Hyll;
    • Tannæs, Tone Møller;
    • Brackmann, Stephan;
    • Olbjørn, Christine;
    • Bergemalm, Daniel;
    • Keita, Åsa V;
    • Gomollon, Fernando;
    • Detlie, Trond Espen;
    • Kalla, Rahul;
    • Satsangi, Jack;
    • Jahnsen, Jørgen;
    • Vatn, Morten Harald;
    • Halfvarson, Jonas;
    • Hov, Johannes Roksund;
    • Ricanek, Petr;
    • Moen, Aina EF
    Publication type:
    Article
    3

    Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis.

    Published in:
    Clinical & Experimental Gastroenterology, 2022, v. 15, p. 129, doi. 10.2147/CEG.S368040
    By:
    • Holst, Luiza Moraes;
    • Halfvarson, Jonas;
    • Carlson, Marie;
    • Hedin, Charlotte;
    • Kruse, Robert;
    • Lindqvist, Carl Mårten;
    • Bergemalm, Daniel;
    • Almér, Sven;
    • Bresso, Francesca;
    • Lundström, Maria Ling;
    • Repsilber, Dirk;
    • D'Amato, Mauro;
    • Keita, Åsa;
    • Hjortswang, Henrik;
    • Söderholm, Johan;
    • Sundin, Johanna;
    • Törnblom, Hans;
    • Simrén, Magnus;
    • Strid, Hans;
    • Magnusson, Maria K
    Publication type:
    Article
    4

    Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort.

    Published in:
    Clinical & Experimental Gastroenterology, 2022, v. 15, p. 5, doi. 10.2147/CEG.S343468
    By:
    • Vatn, Simen Svendsen;
    • Lindstrøm, Jonas Christoffer;
    • Moen, Aina EF;
    • Brackmann, Stephan;
    • Tannæs, Tone M;
    • Olbjørn, Christine;
    • Bergemalm, Daniel;
    • Keita, Åsa V;
    • Gomollon, Fernando;
    • Detlie, Trond Espen;
    • Lüders, Torben;
    • Kalla, Rahul;
    • Adams, Alex;
    • Satsangi, Jack;
    • Jahnsen, Jørgen;
    • Vatn, Morten H;
    • Halfvarson, Jonas;
    • Ricanek, Petr;
    • Nilsen, Hilde
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.

    Published in:
    Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211023386
    By:
    • Eriksson, Carl;
    • Rundquist, Sara;
    • Lykiardopoulos, Vyron;
    • Udumyan, Ruzan;
    • Karlén, Per;
    • Grip, Olof;
    • Söderman, Charlotte;
    • Almer, Sven;
    • Hertervig, Erik;
    • Marsal, Jan;
    • Gunnarsson, Jenny;
    • Malmgren, Carolina;
    • Delin, Jenny;
    • Strid, Hans;
    • Sjöberg, Mats;
    • Öberg, David;
    • Bergemalm, Daniel;
    • Hjortswang, Henrik;
    • Halfvarson, Jonas
    Publication type:
    Article
    11

    Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype Open Access.

    Published in:
    Journal of Crohn's & Colitis, 2025, v. 19, n. 5, p. 1, doi. 10.1093/ecco-jcc/jjaf062
    By:
    • Pertsinidou, Eleftheria;
    • Salomon, Benita;
    • Bergemalm, Daniel;
    • Salihovic, Samira;
    • Hedin, Charlotte R H;
    • Lundström, Maria Ling;
    • Keita, Åsa V;
    • Magnusson, Maria K;
    • Eriksson, Carl;
    • Bengtson, May-Bente;
    • Grännö, Olle;
    • Aabrekk, Tone B;
    • Movérare, Robert;
    • Rydell, Niclas;
    • Ekoff, Helena;
    • Rönnelid, Johan;
    • consortium, BIO-IBD;
    • D'Amato, Mauro;
    • Detlie, Trond E;
    • Huppertz-Hauss, Gert
    Publication type:
    Article
    12

    Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study Open Access.

    Published in:
    Journal of Crohn's & Colitis, 2025, v. 19, n. 5, p. 1, doi. 10.1093/ecco-jcc/jjae169
    By:
    • Salomon, Benita;
    • Sudhakar, Padhmanand;
    • Bergemalm, Daniel;
    • Andersson, Erik;
    • Grännö, Olle;
    • Carlson, Marie;
    • Hedin, Charlotte R H;
    • Söderholm, Johan D;
    • Öhman, Lena;
    • Consortium, the BIO IBD;
    • Lindqvist, Carl Mårten;
    • Kruse, Robert;
    • Repsilber, Dirk;
    • Verstockt, Bram;
    • Vermeire, Séverine;
    • Halfvarson, Jonas
    Publication type:
    Article
    13

    Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease.

    Published in:
    Journal of Crohn's & Colitis, 2023, v. 17, n. 6, p. 919, doi. 10.1093/ecco-jcc/jjad012
    By:
    • Shubhakar, Archana;
    • Jansen, Bas C;
    • Adams, Alex T;
    • Reiding, Karli R;
    • Ventham, Nicholas T;
    • Kalla, Rahul;
    • Bergemalm, Daniel;
    • Urbanowicz, Paulina A;
    • Gardner, Richard A;
    • Consortium, IBD-BIOM;
    • Wuhrer, Manfred;
    • Halfvarson, Jonas;
    • Satsangi, Jack;
    • Fernandes, Daryl L;
    • Spencer, Daniel I R
    Publication type:
    Article
    14

    Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.

    Published in:
    Journal of Crohn's & Colitis, 2023, v. 17, n. 5, p. 722, doi. 10.1093/ecco-jcc/jjac179
    By:
    • Mahajna, Hussein;
    • Verstockt, Bram;
    • Bergemalm, Daniel;
    • Castiglione, Fabiana;
    • Rodríguez-Moranta, Fransisco;
    • Savarino, Edoardo;
    • Hoentjen, Frank;
    • Bessissow, Talat;
    • Pokryszka, Jagoda;
    • Cremer, Anneline;
    • Eder, Piotr;
    • Truyens, Marie;
    • Yerushalmy-Feler, Anat;
    • García, María José;
    • Kopylov, Uri
    Publication type:
    Article
    15

    Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome.

    Published in:
    Journal of Crohn's & Colitis, 2023, v. 17, n. 2, p. 170, doi. 10.1093/ecco-jcc/jjac127
    By:
    • Kalla, Rahul;
    • Adams, Alex T;
    • Nowak, Jan K;
    • Bergemalm, Daniel;
    • Vatn, Simen;
    • Ventham, Nicholas T;
    • Kennedy, Nicholas A;
    • Ricanek, Petr;
    • Lindstrom, Jonas;
    • Consortium, IBD-Character;
    • Söderholm, Johan;
    • Pierik, Marie;
    • D'Amato, Mauro;
    • Gomollón, Fernando;
    • Olbjørn, Christine;
    • Richmond, Rebecca;
    • Relton, Caroline;
    • Jahnsen, Jørgen;
    • Vatn, Morten H;
    • Halfvarson, Jonas
    Publication type:
    Article
    16

    Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2.

    Published in:
    Journal of Crohn's & Colitis, 2022, v. 16, n. 8, p. 1255, doi. 10.1093/ecco-jcc/jjac033
    By:
    • Nowak, Jan K;
    • Adams, Alex T;
    • Kalla, Rahul;
    • Lindstrøm, Jonas C;
    • Vatn, Simen;
    • Bergemalm, Daniel;
    • Keita, Åsa V;
    • Gomollón, Fernando;
    • Jahnsen, Jørgen;
    • Vatn, Morten H;
    • Ricanek, Petr;
    • Ostrowski, Jerzy;
    • Walkowiak, Jaroslaw;
    • Halfvarson, Jonas;
    • Satsangi, Jack;
    • Consortium, IBD Character
    Publication type:
    Article
    17

    Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease.

    Published in:
    Journal of Crohn's & Colitis, 2022, v. 16, n. 7, p. 1097, doi. 10.1093/ecco-jcc/jjac003
    By:
    • Juzenas, Simonas;
    • Hübenthal, Matthias;
    • Lindqvist, Carl Mårten;
    • Kruse, Robert;
    • Steiert, Tim Alexander;
    • Degenhardt, Frauke;
    • Schulte, Dominik;
    • Nikolaus, Susanna;
    • Zeissig, Sebastian;
    • Bergemalm, Daniel;
    • Almer, Sven;
    • Hjortswang, Henrik;
    • Bresso, Francesca;
    • Group, SIC IBD Working;
    • Strüning, Nina;
    • Kupcinskas, Juozas;
    • Keller, Andreas;
    • Lieb, Wolfgang;
    • Rosenstiel, Philip;
    • Schreiber, Stefan
    Publication type:
    Article
    18
    19
    20
    21
    22

    Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).

    Published in:
    Scandinavian Journal of Gastroenterology, 2017, v. 52, n. 6/7, p. 722, doi. 10.1080/00365521.2017.1304987
    By:
    • Eriksson, Carl;
    • Marsal, Jan;
    • Bergemalm, Daniel;
    • Vigren, Lina;
    • Björk, Jan;
    • Eberhardson, Michael;
    • Karling, Pontus;
    • Söderman, Charlotte;
    • Myrelid, Pär;
    • Cao, Yang;
    • Sjöberg, Daniel;
    • Thörn, Mari;
    • Karlén, Per;
    • Hertervig, Erik;
    • Strid, Hans;
    • Ludvigsson, Jonas F.;
    • Almer, Sven;
    • Halfvarson, Jonas
    Publication type:
    Article
    23
    24

    Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.

    Published in:
    Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231174953
    By:
    • Visuri, Isabella;
    • Eriksson, Carl;
    • Karlqvist, Sara;
    • Lykiardopoulos, Byron;
    • Karlén, Per;
    • Grip, Olof;
    • Söderman, Charlotte;
    • Almer, Sven;
    • Hertervig, Erik;
    • Marsal, Jan;
    • Malmgren, Carolina;
    • Delin, Jenny;
    • Strid, Hans;
    • Sjöberg, Mats;
    • Bergemalm, Daniel;
    • Hjortswang, Henrik;
    • Halfvarson, Jonas
    Publication type:
    Article
    25

    Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.

    Published in:
    Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231174953
    By:
    • Visuri, Isabella;
    • Eriksson, Carl;
    • Karlqvist, Sara;
    • Lykiardopoulos, Byron;
    • Karlén, Per;
    • Grip, Olof;
    • Söderman, Charlotte;
    • Almer, Sven;
    • Hertervig, Erik;
    • Marsal, Jan;
    • Malmgren, Carolina;
    • Delin, Jenny;
    • Strid, Hans;
    • Sjöberg, Mats;
    • Bergemalm, Daniel;
    • Hjortswang, Henrik;
    • Halfvarson, Jonas;
    • The SWIBREG SVEAH Study Group
    Publication type:
    Article
    26

    Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.

    Published in:
    Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211023386
    By:
    • Eriksson, Carl;
    • Rundquist, Sara;
    • Lykiardopoulos, Vyron;
    • Udumyan, Ruzan;
    • Karlén, Per;
    • Grip, Olof;
    • Söderman, Charlotte;
    • Almer, Sven;
    • Hertervig, Erik;
    • Marsal, Jan;
    • Gunnarsson, Jenny;
    • Malmgren, Carolina;
    • Delin, Jenny;
    • Strid, Hans;
    • Sjöberg, Mats;
    • Öberg, David;
    • Bergemalm, Daniel;
    • Hjortswang, Henrik;
    • Halfvarson, Jonas
    Publication type:
    Article
    27
    28
    29